Universe Pharmaceuticals (UPC) Receivables (2020 - 2025)
Historic Receivables for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $2293.7 billion.
- Universe Pharmaceuticals' Receivables rose 1216089.24% to $2293.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2293.7 billion, marking a year-over-year increase of 1216089.24%. This contributed to the annual value of $2293.7 billion for FY2025, which is 1216089.24% up from last year.
- According to the latest figures from Q3 2025, Universe Pharmaceuticals' Receivables is $2293.7 billion, which was up 1216089.24% from $18.7 billion recorded in Q3 2024.
- Universe Pharmaceuticals' 5-year Receivables high stood at $2293.7 billion for Q3 2025, and its period low was $14.4 million during Q1 2024.
- Its 5-year average for Receivables is $289.1 billion, with a median of $18.3 million in 2022.
- In the last 5 years, Universe Pharmaceuticals' Receivables crashed by 9999.99% in 2021 and then soared by 1216089.24% in 2025.
- Quarter analysis of 5 years shows Universe Pharmaceuticals' Receivables stood at $15.8 million in 2021, then grew by 1.04% to $16.0 million in 2022, then skyrocketed by 2419.97% to $402.6 million in 2023, then soared by 4546.87% to $18.7 billion in 2024, then surged by 12160.89% to $2293.7 billion in 2025.
- Its Receivables was $2293.7 billion in Q3 2025, compared to $18.7 billion in Q3 2024 and $14.4 million in Q1 2024.